Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
2024-04-09 10:27:56 ET More on Bayer, Bayer AG, etc. ChatGPT Is An Existential Threat To Google Search's Ad-Based Model Google Is Still A Long-Term Buy Amid Its Gemini Troubles Google: Gemini Controversy Provides AI Opportunity Dynatrace expands partnership w...
2024-04-09 10:25:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2024-04-08 09:41:08 ET J.P.Morgan analysts published a list of European companies that would suffer due to higher financing costs. ... Read the full article on Seeking Alpha For further details see: European losers of higher financing costs - JPMorgan
2024-04-05 16:43:51 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...
2024-03-21 12:53:07 ET More on Boundless Bio, Inc. Boundless Bio Starts $100 Million U.S. IPO Plan IPO Roundup: Boundless Bio, NeOnc Technologies and more Oncology drug developer Boundless Bio files for $100M IPO Financial information for Boundless Bio, Inc. ...
2024-03-19 06:19:29 ET Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said Tuesday it would seek marketing approval for its experimental menopause treatment, elinzanetant, after the drug was shown to reduce the frequency of hot flashes associated with menopause in a third late-stage trial......
2024-03-13 17:43:59 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...
2024-03-13 08:10:58 ET Summary US stocks climbed higher in February with the DJIA adding 0.4% and the S&P closing in on the 5,000-point mark. Interest rates were kept steady again in a range of 5.25% to 5.5%, with the market now projecting fewer hikes this year as the economy ...
2024-03-12 12:09:42 ET Summary Bicycle Therapeutics plc results from the phase 1/2 Duravelo-1 study, using BT8009 for the treatment of patients with metastatic urothelial carcinoma, expected in the 2nd half of 2024. Data from BT5528 [Bicycle toxin conjugate tech] and BT7480 [Bicyc...
2024-03-08 17:31:07 ET More on Bold Capital Enterprises Ltd. Financial information for Bold Capital Enterprises Ltd. Read the full article on Seeking Alpha For further details see: Oncology drug developer Boundless Bio files for $100M IPO
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
Bayer AG (OTC:BAYRY) (OTC:BAYZF) will present detailed results from the Phase 3 studies OASIS 1 and 2, showing that the investi...
Bayer AG’s (OTC:BAYRY) (OTC:BAYZF) Monsanto unit secured a significant victory. A Washington state appeals court overturned a ...
Bayer AG (OTC:BAYRY) (OTC:BAYZF) is reportedly considering utilizing the Texas Two-Step bankruptcy approach to tackle the onslaught of lawsuit...